Supply Chain
Long wait times, crowded waiting rooms, and frustrated staff are often symptoms of inefficient workflows driven by physical space constraints.…
McKesson Corp. selected Brad Lerman to serve as an independent director on its board, effective April 24.
Here are the four latest drugs or medical devices approved by the FDA since April 13.
The FDA approved Ultragenyx Pharmaceutical's drug Crysvita April 17 to treat patients with a rare, inherited form of rickets known as x-linked hypophosphatemia.
The shifting healthcare cost curve is pressuring providers to reduce costs and improve quality.
Vizient, a group purchasing organization, selected David F. Ertel to serve as CFO, effective May 22.
Physicians are turning to less effective treatment options for some liver cancer patients after Johnson & Johnson subsidiary Cerenovus discontinued production of an implantable chemotherapy pump known to significantly extend cancer patients' lives, reports The New York Times.
After an almost four-year criminal investigation into generic drugmakers for alleged price-fixing, U.S. antitrust prosecutors are expected to file charges against two companies and several executives in the coming months, reports Bloomberg.
A streamlined freight management strategy presents significant cost savings opportunities for hospitals and health systems.
Medline entered into a strategic agreement with Cooperstown, N.Y.-based Bassett Healthcare to help the health system create a more efficient and patient-centered supply chain, the company announced April 5.
Medline installed a solar power system at its facility in Rialto, Calif., the company announced April 20.